JP2010535015A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535015A5 JP2010535015A5 JP2010517242A JP2010517242A JP2010535015A5 JP 2010535015 A5 JP2010535015 A5 JP 2010535015A5 JP 2010517242 A JP2010517242 A JP 2010517242A JP 2010517242 A JP2010517242 A JP 2010517242A JP 2010535015 A5 JP2010535015 A5 JP 2010535015A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- monoclonal antibody
- produced
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96172307P | 2007-07-23 | 2007-07-23 | |
| PCT/CA2008/001353 WO2009012588A1 (en) | 2007-07-23 | 2008-07-23 | Immunogenic polypeptides and monoclonal antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013089148A Division JP6204053B2 (ja) | 2007-07-23 | 2013-04-22 | 免疫原性のポリペプチドおよびモノクローナル抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010535015A JP2010535015A (ja) | 2010-11-18 |
| JP2010535015A5 true JP2010535015A5 (enExample) | 2011-08-11 |
Family
ID=40280955
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010517242A Pending JP2010535015A (ja) | 2007-07-23 | 2008-07-23 | 免疫原性のポリペプチドおよびモノクローナル抗体 |
| JP2013089148A Expired - Fee Related JP6204053B2 (ja) | 2007-07-23 | 2013-04-22 | 免疫原性のポリペプチドおよびモノクローナル抗体 |
| JP2015196681A Pending JP2016005482A (ja) | 2007-07-23 | 2015-10-02 | 免疫原性のポリペプチドおよびモノクローナル抗体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013089148A Expired - Fee Related JP6204053B2 (ja) | 2007-07-23 | 2013-04-22 | 免疫原性のポリペプチドおよびモノクローナル抗体 |
| JP2015196681A Pending JP2016005482A (ja) | 2007-07-23 | 2015-10-02 | 免疫原性のポリペプチドおよびモノクローナル抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8337846B2 (enExample) |
| EP (1) | EP2183366B1 (enExample) |
| JP (3) | JP2010535015A (enExample) |
| KR (1) | KR101595234B1 (enExample) |
| CN (1) | CN101802198B (enExample) |
| AU (1) | AU2008280799B2 (enExample) |
| BR (1) | BRPI0814127A2 (enExample) |
| CA (1) | CA2694466A1 (enExample) |
| ES (1) | ES2397488T3 (enExample) |
| IL (1) | IL203429A0 (enExample) |
| WO (1) | WO2009012588A1 (enExample) |
| ZA (1) | ZA201001260B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
| WO2011075822A1 (en) | 2009-12-22 | 2011-06-30 | Sanofi Pasteur Limited | Immunogenic compositions and related methods |
| KR20120107121A (ko) | 2009-12-22 | 2012-09-28 | 사노피 파스퇴르 리미티드 | 면역원성 조성물 |
| GB201003920D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
| AU2011336366B2 (en) | 2010-12-03 | 2016-05-12 | Sanofi Pasteur Limited | Composition for immunization against Streptococcus pneumoniae |
| KR20140033127A (ko) | 2011-05-17 | 2014-03-17 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 스트렙토코쿠스 뉴모니애에 대한 백신 |
| EP2810078A4 (en) * | 2012-02-01 | 2016-02-17 | Oklahoma Med Res Found | HUMAN STREPTOCOCCUS PNEUMONIAE ANTIBODIES AND APPLICATIONS THEREOF |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| CN105754952B (zh) * | 2016-02-16 | 2020-07-10 | 中国农业科学院兰州兽医研究所 | 抗羊痘病毒k3l蛋白c末端的单克隆抗体及其应用 |
| GB201610599D0 (en) | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
| GB201711635D0 (en) | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| WO2019180618A1 (en) * | 2018-03-20 | 2019-09-26 | Sanofi Pasteur Limited | Methods for determining adjuvanted protein concentration and percent adsorption using intrinsic fluorescence |
| CN117396502A (zh) * | 2021-02-09 | 2024-01-12 | 佐治亚大学研究基金会有限公司 | 针对肺炎球菌抗原的人类单克隆抗体 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL81370A (en) * | 1986-02-07 | 1991-06-30 | Genetic Systems Corp | Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions |
| ES2198405T3 (es) * | 1991-11-22 | 2004-02-01 | Nabi Biopharmaceuticals | Antigenos de superficie de tipo i asociados a staphylococcus epidermis. |
| US6582708B1 (en) * | 2000-06-28 | 2003-06-24 | The Procter & Gamble Company | Tooth whitening substance |
| CA2355364C (en) | 1998-12-21 | 2014-03-18 | Medimmune, Inc. | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| US7128918B1 (en) * | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
| PL205041B1 (pl) * | 1998-12-23 | 2010-03-31 | Id Biomedical Corp | Izolowany polinukleotyd, wektor zawierający izolowany polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca polipeptyd oraz jej zastosowanie w leczeniu lub zapobieganiu zakażeniu osobnika paciorkowcem |
| CN1198932C (zh) * | 1999-03-26 | 2005-04-27 | 科特克斯(Om)有限公司 | 肺炎链球菌抗原 |
| EP1290019A2 (en) * | 2000-06-14 | 2003-03-12 | Cytovax Biotechnologies Inc. | Use of coiled-coil structural scaffold to generate structure-specific peptides |
| WO2001098334A2 (en) * | 2000-06-20 | 2001-12-27 | Shire Biochem Inc. | Streptococcus antigens |
| US7074415B2 (en) * | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
| GB0022742D0 (en) * | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| GB0130215D0 (en) | 2001-12-18 | 2002-02-06 | Glaxosmithkline Biolog Sa | Vaccine |
| US7262024B2 (en) * | 2001-12-20 | 2007-08-28 | Id Biomedical Corporation | Streptococcus antigens |
| US6720918B2 (en) * | 2002-09-17 | 2004-04-13 | Space Systems/Loral, Inc. | Antenna distortion estimation and compensation |
| US7635487B2 (en) * | 2003-04-15 | 2009-12-22 | Intercell Ag | S. pneumoniae antigens |
| AU2004257206A1 (en) * | 2003-07-10 | 2005-01-27 | Wyeth Holdings Corporation | Recombinant expression of Streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| EP1919934A2 (en) * | 2005-05-13 | 2008-05-14 | Novartis Vaccines and Diagnostics, Inc. | Serum resistance factors of gram positive bacteria |
| JP5509176B2 (ja) * | 2011-10-21 | 2014-06-04 | 株式会社日立製作所 | 計算機システムおよび計算機システムにおけるモジュール引き継ぎ方法 |
-
2008
- 2008-07-23 CA CA2694466A patent/CA2694466A1/en not_active Abandoned
- 2008-07-23 BR BRPI0814127-4A2A patent/BRPI0814127A2/pt not_active Application Discontinuation
- 2008-07-23 US US12/670,150 patent/US8337846B2/en not_active Expired - Fee Related
- 2008-07-23 CN CN200880108203.5A patent/CN101802198B/zh not_active Expired - Fee Related
- 2008-07-23 JP JP2010517242A patent/JP2010535015A/ja active Pending
- 2008-07-23 WO PCT/CA2008/001353 patent/WO2009012588A1/en not_active Ceased
- 2008-07-23 EP EP08783266A patent/EP2183366B1/en not_active Not-in-force
- 2008-07-23 ES ES08783266T patent/ES2397488T3/es active Active
- 2008-07-23 KR KR1020107003640A patent/KR101595234B1/ko not_active Expired - Fee Related
- 2008-07-23 AU AU2008280799A patent/AU2008280799B2/en not_active Ceased
-
2010
- 2010-01-21 IL IL203429A patent/IL203429A0/en unknown
- 2010-02-22 ZA ZA201001260A patent/ZA201001260B/xx unknown
-
2013
- 2013-04-22 JP JP2013089148A patent/JP6204053B2/ja not_active Expired - Fee Related
-
2015
- 2015-10-02 JP JP2015196681A patent/JP2016005482A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112010965A (zh) | 一种针对新冠病毒SARS-CoV-2棘突蛋白RBD区的单克隆抗体及其应用 | |
| CN105073196B (zh) | 呼吸道合胞病毒f蛋白表位 | |
| JP4310184B2 (ja) | 呼吸器合胞体ウイルス（ｒｓｖ）ｇタンパク質のペプチドとワクチンにおけるその利用 | |
| Basset et al. | Toll-like receptor (TLR) 2 mediates inflammatory responses to oligomerized RrgA pneumococcal pilus type 1 protein | |
| JP2012515551A5 (enExample) | ||
| RU2194757C2 (ru) | ФРАГМЕНТ ДНК, КОДИРУЮЩИЙ ФРАГМЕНТ БЕЛКА РЕЦЕПТОРА ТРАНСФЕРРИНА ШТАММА Haemophilus (ВАРИАНТЫ), ПЛАЗМИДНЫЙ ВЕКТОР (ВАРИАНТЫ), РЕКОМБИНАНТНЫЙ БЕЛОК (ВАРИАНТЫ), ВЫДЕЛЕННЫЙ И ОЧИЩЕННЫЙ БЕЛОК (ВАРИАНТЫ), ИММУНОГЕННАЯ КОМПОЗИЦИЯ И СПОСОБ ПОЛУЧЕНИЯ ВЫДЕЛЕННОГО И ОЧИЩЕННОГО БЕЛКА | |
| EP3279217B1 (en) | Streptococcus pneumoniae protein antigen, and preparation method and use thereof | |
| CA2410604A1 (en) | Use of coiled-coil structural scaffold to generate structure-specific peptides | |
| CN113173977B (zh) | 一种双功能抗原、其制备方法及应用 | |
| JP2002517218A (ja) | ワクチン | |
| CN104450627A (zh) | 鲤疱疹病毒3型囊膜蛋白orf132的单克隆抗体、杂交瘤细胞株及其应用 | |
| CN110642927A (zh) | 一种蛋白在制备预防化脓隐秘杆菌感染的药物中的应用 | |
| Kumar et al. | Structural analysis and cross-protective efficacy of recombinant 87 kDa outer membrane protein (Omp87) of Pasteurella multocida serogroup B: 2 | |
| US20100143394A1 (en) | Synthetic streptococcus pneumoniae vaccine | |
| EP0567470B1 (en) | Pseudomonas peptide composition and method for producing the same | |
| CN103724413B (zh) | 旋毛虫副肌球蛋白b细胞抗原表位8a1及其应用 | |
| CN108794584B (zh) | 一种胸膜肺炎放线杆菌免疫保护性抗原蛋白apjl_1380及其应用 | |
| CN112522210B (zh) | 一种分泌抗小反刍兽疫病毒单克隆抗体的杂交瘤细胞株及其单抗与应用 | |
| CN118406142B (zh) | 抗a族链球菌m蛋白保守表位肽的单克隆抗体及其应用 | |
| CN112574297B (zh) | 抗神经氨酸酶的单克隆抗体及其应用 | |
| Vorobieva et al. | Analysis of recombinant group B streptococcal protein ScaAB and evaluation of its immunogenicity | |
| Meinke et al. | Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens | |
| CN1367833B (zh) | 肺炎链球菌的蛋白质和核酸分子 | |
| CA2328130A1 (en) | Moraxella catarrhalis proteins | |
| CN105542003A (zh) | 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体 |